357 related articles for article (PubMed ID: 16200232)
1. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.
Gheorghe L; Iacob R; Vădan R; Iacob S; Gheorghe C
Rom J Gastroenterol; 2005 Sep; 14(3):231-8. PubMed ID: 16200232
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
3. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
[TBL] [Abstract][Full Text] [Related]
4. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].
Yang CS; Cao SY; He XJ; Wang YX; Zhang YL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712
[TBL] [Abstract][Full Text] [Related]
5. Nutrition in hepatic encephalopathy.
Chadalavada R; Sappati Biyyani RS; Maxwell J; Mullen K
Nutr Clin Pract; 2010 Jun; 25(3):257-64. PubMed ID: 20581319
[TBL] [Abstract][Full Text] [Related]
6. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.
Kalaitzakis E; Olsson R; Henfridsson P; Hugosson I; Bengtsson M; Jalan R; Björnsson E
Liver Int; 2007 Nov; 27(9):1194-201. PubMed ID: 17919230
[TBL] [Abstract][Full Text] [Related]
7. Effects of an appropriate oral diet on the nutritional status of patients with HCV-related liver cirrhosis: a prospective study.
Manguso F; D'Ambra G; Menchise A; Sollazzo R; D'Agostino L
Clin Nutr; 2005 Oct; 24(5):751-9. PubMed ID: 16182039
[TBL] [Abstract][Full Text] [Related]
8. Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.
Ndraha S; Simadibrata M
Acta Med Indones; 2010 Jul; 42(3):158-61. PubMed ID: 20724770
[TBL] [Abstract][Full Text] [Related]
9. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study.
Córdoba J; López-Hellín J; Planas M; Sabín P; Sanpedro F; Castro F; Esteban R; Guardia J
J Hepatol; 2004 Jul; 41(1):38-43. PubMed ID: 15246205
[TBL] [Abstract][Full Text] [Related]
10. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
Sharma P; Sharma BC; Sarin SK
Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
[TBL] [Abstract][Full Text] [Related]
11. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
12. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
[TBL] [Abstract][Full Text] [Related]
13. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
Quero JC; Hartmann IJ; Meulstee J; Hop WC; Schalm SW
Hepatology; 1996 Sep; 24(3):556-60. PubMed ID: 8781324
[TBL] [Abstract][Full Text] [Related]
14. Dietary protein supplementation from vegetable sources in the management of chronic portal systemic encephalopathy.
Keshavarzian A; Meek J; Sutton C; Emery VM; Hughes EA; Hodgson HJ
Am J Gastroenterol; 1984 Dec; 79(12):945-9. PubMed ID: 6391154
[TBL] [Abstract][Full Text] [Related]
15. [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies].
Boca M; Vyskocil M; Mikulecký M; Ebringer L; Kolibás E; Kratochvíl'ová H; Buzgová D
Cas Lek Cesk; 2004; 143(5):324-8. PubMed ID: 15305769
[TBL] [Abstract][Full Text] [Related]
16. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
17. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis.
Gad YZ; Zaher AA; Moussa NH; El-desoky AE; Al-Adarosy HA
Arab J Gastroenterol; 2011 Jun; 12(2):58-61. PubMed ID: 21684474
[TBL] [Abstract][Full Text] [Related]
18. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
[TBL] [Abstract][Full Text] [Related]
19. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
Sharma BC; Sharma P; Agrawal A; Sarin SK
Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
[TBL] [Abstract][Full Text] [Related]
20. Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Wen J; Liu Q; Song J; Tong M; Peng L; Liang H
Digestion; 2013; 87(2):132-8. PubMed ID: 23485720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
